These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy. Wu KY; Lin KJ; Chen CH; Chen CS; Liu CY; Huang SY; Yen TC; Hsiao IT Brain Behav; 2018 Jul; 8(7):e01016. PubMed ID: 29927088 [TBL] [Abstract][Full Text] [Related]
26. Subthreshold Amyloid Predicts Tau Deposition in Aging. Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045 [TBL] [Abstract][Full Text] [Related]
27. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC). Barker W; Quinonez C; Greig MT; Behar R; Chirinos C; Rodriguez RA; Rosselli M; Rodriguez MJ; Cid RC; Rundek T; McFarland K; Hanson K; Smith G; DeKosky S; Vaillancourt D; Adjouadi M; Marsiske M; Ertekin-Taner N; Golde T; Loewenstein DA; Duara R J Alzheimers Dis; 2021; 79(1):59-70. PubMed ID: 33216030 [TBL] [Abstract][Full Text] [Related]
28. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Thomas KR; Bangen KJ; Weigand AJ; Edmonds EC; Wong CG; Cooper S; Delano-Wood L; Bondi MW; Neurology; 2020 Jan; 94(4):e397-e406. PubMed ID: 31888974 [TBL] [Abstract][Full Text] [Related]
29. β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Fletcher E; Villeneuve S; Maillard P; Harvey D; Reed B; Jagust W; DeCarli C Neurobiol Aging; 2016 Apr; 40():173-180. PubMed ID: 26973117 [TBL] [Abstract][Full Text] [Related]
31. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community. Petersen RC; Wiste HJ; Weigand SD; Rocca WA; Roberts RO; Mielke MM; Lowe VJ; Knopman DS; Pankratz VS; Machulda MM; Geda YE; Jack CR JAMA Neurol; 2016 Jan; 73(1):85-92. PubMed ID: 26595683 [TBL] [Abstract][Full Text] [Related]
32. Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease. Kothapalli SVVN; Benzinger TL; Aschenbrenner AJ; Perrin RJ; Hildebolt CF; Goyal MS; Fagan AM; Raichle ME; Morris JC; Yablonskiy DA J Alzheimers Dis; 2022; 85(2):905-924. PubMed ID: 34897083 [TBL] [Abstract][Full Text] [Related]